United Therapeutics Corporation Payments of Debt Issuance Costs
United Therapeutics Corporation (UTHR) reported Payments of Debt Issuance Costs of $3.40 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfDebtIssuanceCosts · last filed 2026-08-05
- United Therapeutics Corporation payments of debt issuance costs for the quarter ending 2025-12-31 was $0.00.
- United Therapeutics Corporation payments of debt issuance costs for the quarter ending 2025-09-30 was $0.00.
- United Therapeutics Corporation payments of debt issuance costs for the quarter ending 2025-06-30 was $11.50M.
- United Therapeutics Corporation payments of debt issuance costs for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- United Therapeutics Corporation payments of debt issuance costs for fiscal 2025 was $11.50M, a 325.93% increase from fiscal 2024.
- United Therapeutics Corporation payments of debt issuance costs for fiscal 2024 was $2.70M, a 0.00% change from fiscal 2023.
- United Therapeutics Corporation payments of debt issuance costs for fiscal 2023 was $2.70M, a 64.00% decline from fiscal 2022.
- United Therapeutics Corporation payments of debt issuance costs for fiscal 2022 was $7.50M.
| Period end | Payments of Debt Issuance Costs 3 month | Payments of Debt Issuance Costs 6 month | Payments of Debt Issuance Costs 9 month | Payments of Debt Issuance Costs 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.40M 10-Q · filed 2026-08-05 | |||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $0.00 derived: sum of 2 quarters · filed 2026-02-25 | $11.50M derived: sum of 3 quarters · filed 2026-08-05 | $11.50M 10-K · filed 2026-02-25 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $11.50M derived: sum of 2 quarters · filed 2026-08-05 | $11.50M 10-Q · filed 2025-10-29 | $11.50M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $11.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $11.50M 10-Q · filed 2026-08-05 | $11.50M derived: sum of 3 quarters · filed 2026-08-05 | $11.50M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $0.00 10-Q · filed 2025-04-30 | $0.00 derived: sum of 2 quarters · filed 2026-02-25 | $0.00 derived: sum of 3 quarters · filed 2026-02-25 | $0.00 derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $0.00 derived: sum of 2 quarters · filed 2026-02-25 | $0.00 derived: sum of 3 quarters · filed 2026-02-25 | $2.70M 10-K · filed 2026-02-25 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $0.00 derived: sum of 2 quarters · filed 2025-10-29 | $2.70M 10-Q · filed 2025-10-29 | $2.70M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $2.70M 10-Q · filed 2025-07-30 | $2.70M derived: sum of 3 quarters · filed 2026-02-25 | $2.70M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $2.70M 10-Q · filed 2025-04-30 | $2.70M derived: sum of 2 quarters · filed 2026-02-25 | $2.70M derived: sum of 3 quarters · filed 2026-02-25 | $2.70M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $0.00 derived: sum of 2 quarters · filed 2026-02-25 | $0.00 derived: sum of 3 quarters · filed 2026-02-25 | $2.70M 10-K · filed 2026-02-25 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $0.00 derived: sum of 2 quarters · filed 2024-10-30 | $2.70M 10-Q · filed 2024-10-30 | $2.70M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | $2.70M 10-Q · filed 2024-07-31 | $2.70M derived: sum of 3 quarters · filed 2025-02-26 | $2.70M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | $2.70M 10-Q · filed 2024-05-01 | $2.70M derived: sum of 2 quarters · filed 2025-02-26 | $2.70M derived: sum of 3 quarters · filed 2025-02-26 | $2.70M derived: sum of 4 quarters · filed 2025-02-26 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $0.00 derived: sum of 2 quarters · filed 2025-02-26 | $0.00 derived: sum of 3 quarters · filed 2025-02-26 | $7.50M 10-K · filed 2025-02-26 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $0.00 derived: sum of 2 quarters · filed 2023-11-01 | $7.50M 10-Q · filed 2023-11-01 | $7.50M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $7.50M 10-Q · filed 2023-08-02 | $7.50M derived: sum of 3 quarters · filed 2024-02-21 | $7.50M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-03-31 | $7.50M 10-Q · filed 2023-05-03 | $7.50M derived: sum of 2 quarters · filed 2024-02-21 | $7.50M derived: sum of 3 quarters · filed 2024-02-21 | $7.50M derived: sum of 4 quarters · filed 2024-02-21 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $0.00 derived: sum of 2 quarters · filed 2024-02-21 | $0.00 derived: sum of 3 quarters · filed 2024-02-21 | $0.00 10-K · filed 2024-02-21 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $0.00 derived: sum of 2 quarters · filed 2022-11-02 | $0.00 10-Q · filed 2022-11-02 | $1.70M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $0.00 10-Q · filed 2022-08-03 | $1.70M derived: sum of 3 quarters · filed 2023-02-22 | $1.70M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-04 | $1.70M derived: sum of 2 quarters · filed 2023-02-22 | $1.70M derived: sum of 3 quarters · filed 2023-02-22 | |
| 2020-12-31 | $1.70M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $1.70M derived: sum of 2 quarters · filed 2023-02-22 | $1.70M 10-K · filed 2023-02-22 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-28 | $0.00 10-Q · filed 2020-10-28 | ||
| 2020-06-30 | $0.00 10-Q · filed 2020-07-29 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $0.00 derived: sum of 2 quarters · filed 2022-02-24 | $700.00K 10-K · filed 2022-02-24 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-28 | $700.00K 10-Q · filed 2020-10-28 | ||
| 2019-06-30 | $700.00K 10-Q · filed 2020-07-29 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $0.00 derived: sum of 2 quarters · filed 2021-02-24 | $12.50M derived: sum of 3 quarters · filed 2021-02-24 | $13.20M 10-K · filed 2021-02-24 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | $12.50M derived: sum of 2 quarters · filed 2019-10-30 | $13.20M 10-Q · filed 2019-10-30 | $13.20M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-06-30 | $12.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | $13.20M 10-Q · filed 2019-07-31 | $13.20M derived: sum of 3 quarters · filed 2020-02-26 | $13.20M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-03-31 | $700.00K 10-Q · filed 2019-05-01 | $700.00K derived: sum of 2 quarters · filed 2020-02-26 | $700.00K derived: sum of 3 quarters · filed 2020-02-26 | $700.00K derived: sum of 4 quarters · filed 2020-02-26 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $0.00 derived: sum of 2 quarters · filed 2020-02-26 | $0.00 derived: sum of 3 quarters · filed 2020-02-26 | $700.00K 10-K · filed 2020-02-26 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | $0.00 derived: sum of 2 quarters · filed 2018-10-31 | $700.00K 10-Q · filed 2018-10-31 | $700.00K derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $700.00K 10-Q · filed 2018-08-01 | $700.00K derived: sum of 3 quarters · filed 2019-02-27 | $700.00K derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-03-31 | $700.00K 10-Q · filed 2018-05-02 | $700.00K derived: sum of 2 quarters · filed 2019-02-27 | $700.00K derived: sum of 3 quarters · filed 2019-02-27 | $700.00K derived: sum of 4 quarters · filed 2019-02-27 |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $0.00 derived: sum of 2 quarters · filed 2019-02-27 | $0.00 derived: sum of 3 quarters · filed 2019-02-27 | $6.80M 10-K · filed 2019-02-27 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-25 | $0.00 derived: sum of 2 quarters · filed 2017-10-25 | $6.80M 10-Q · filed 2017-10-25 | |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-27 | $6.80M 10-Q · filed 2017-07-27 | ||
| 2016-03-31 | $6.80M 10-Q · filed 2017-04-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |